phone user play-button play-button-1 play-button-bold clock maps-and-flags check-mark exclamation star stopwatch schedule calendar pharmacy shopping-bag plus computer pin clock-alt Lifted Logic Web Design in Kansas City clock location phone play chevron-down chevron-left chevron-right chevron-up checkbox checkbox-checked radio radio-selected google plus pinterest send linkedin rs facebook twitter twitter-alt facebook-alt instagram youtube envelope

Daxxify…Better than Botox?

EVOLV / October 4, 2022

Since its discovery for the reduction of facial aging lines and wrinkles in 1989, and approval in 2002, Botox injections have consistently been one of the most popular and studied medications and the number one requested aesthetic treatment for many years.  In addition to cosmetic applications to reduce the signs of aging, Botox has also had remarkable popularity and success in medical applications such as migraine headache therapy, muscle contraction problems such as overactive bladder, cervical and limb spasticity, and even benefitting rosacea and excessive sweating conditions.

On September 8 of this year, the United States Food and Drug Administration (FDA) announced the formal approval of Daxibotulinumtoxin A, known as Daxxify, from Revance Therapeutics for treating glabellar lines or the ’11’s’ or scowl lines between the eyebrows.  In addition, the injectable treatment Daxxify is also being evaluated for the treatment of dynamic lines and wrinkles of other areas on the face including crow’s feet, forehead, and aging lines as well as medical conditions such as migraine and muscle spasticity conditions.

The Daxxify Difference

The considerable excitement around Daxxify involves several key advantages and benefits:

Duration of effect: In multiple clinical trials, the daxibotulinumtoxin A effect in reducing dynamic wrinkles was found to last approximately 6 to 9 months which is 50% longer than the typical 3 to 4 months effect of all other popular neuromodulators such as Botox, Dysport, Xeomin, and Jeuveau.

Stability and purity: Unlike other injectable neuromodulator products, the unique and proprietary technology developed to manufacture Daxxify does not require any human or animal components and has the advantage of stability at room temperatures which help contribute to its uniquely long-lasting results.

Safety and efficacy: In multiple clinical trials involving thousands of patients, Daxxify was shown to be 98% effective after one month of treatment, with over 80% of patients still noticing benefits after 4 months, and approximately 50% enjoying improvements beyond 6 months.  Just as importantly, no serious complications or side effects were observed, other than an occasional headache or temporary bruising, as a result of Daxxify treatments.

          *Before & After images of an EVOLV Botox patient.

As the region’s most experienced leader in surgical and non-surgical aesthetic programs, the professionals at EVOLV Plastic Surgery and Medical Aesthetics are passionate about bringing the most cutting edge and proven technology, products, and services to improve the effects of aging and benefit the quality of life for all our patients.  We believe Daxxify from Revance Therapeutics will provide considerable benefits to our aesthetic programs because of its unique longevity and duration of effect in reducing the signs of facial aging from dynamic glabellar forehead lines and wrinkles as well as offer exciting future applications for other facial areas and medical applications. We expect to have Daxxify available for patient treatment at EVOLV in early 2023.

If you would like to learn more about Daxxify and its potential benefits, please contact any of our EVOLV professionals by giving us a call EVOLV at 419-720-2008 or contact us online to book an appointment.